1 Min Read
Feb 20 (Reuters) - China National Medicines Corp Ltd
* Says it gets securities regulator’s approval for asset acquisition
Source text in Chinese: bit.ly/2kZ2iyO
Further company coverage: (Reporting by Hong Kong newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.